10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG)

Historical Holders from Q3 2019 to Q3 2025

Symbol
TXG on Nasdaq
Type / Class
Equity / Class A common stock, par value $0.00001 per share
Shares outstanding
114M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
123M
Holdings value
$1.44B
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
309
Number of buys
162
Number of sells
-131
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 11.6% $155M 13.3M The Vanguard Group 30 Sep 2025
ARK Investment Management LLC 10.39% -12.3% $139M -$11.2M 11.9M -7.46% ARK Investment Management LLC 30 Sep 2025
FMR LLC 8.1% -22% $109M -$26.3M 9.28M -19.5% FMR LLC 30 Sep 2025
BlackRock, Inc. 7.6% $98.4M 8.5M BlackRock, Inc. 30 Jun 2025
Sumitomo Mitsui Trust Group, Inc. 4.7% -14% $62.9M -$7.4M 5.38M -10.5% Sumitomo Mitsui Trust Group, Inc. 30 Sep 2025
Amova Asset Management Americas, Inc. 4.7% -14% $62.9M -$7.4M 5.38M -10.5% Amova Asset Management Americas, Inc. 30 Sep 2025
MILLENNIUM MANAGEMENT LLC 2.7% -48% $36.9M -$29.8M 3.06M -44.7% Millennium Management LLC 30 Jun 2025

Institutional Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 123M $1.44B +$7.49M $11.69 309
2025 Q2 123M $1.42B +$120M $11.58 293
2025 Q1 114M $993M +$50.9M $8.73 269
2024 Q4 105M $1.5B -$41.9M $14.36 270
2024 Q3 104M $2.36B -$6.3M $22.58 258
2024 Q2 105M $2.05B +$7.1M $19.45 254
2024 Q1 103M $3.86B +$222M $37.53 280
2023 Q4 96M $5.37B +$202M $55.96 267
2023 Q3 90.9M $3.75B +$66.1M $41.25 252
2023 Q2 89.1M $4.98B -$57.6M $55.84 269
2023 Q1 90.2M $5.03B +$211M $55.79 255
2022 Q4 87.5M $3.19B +$105M $36.44 253
2022 Q3 86.1M $2.45B -$43.8M $28.48 208
2022 Q2 86.1M $3.91B +$83.8M $45.25 228
2022 Q1 82.8M $6.29B -$74.1M $76.07 286
2021 Q4 79.8M $11.9B +$65M $148.96 347
2021 Q3 78.8M $11.5B +$128M $145.58 317
2021 Q2 77.9M $15.2B +$1.52B $195.82 332
2021 Q1 70.5M $12.8B +$832M $181.00 310
2020 Q4 66.2M $9.38B -$750M $141.60 299
2020 Q3 69.1M $8.55B +$1.07B $124.68 215
2020 Q2 61M $5.45B +$1.16B $89.31 141
2020 Q1 38.9M $2.43B +$613M $62.32 102
2019 Q4 30.8M $2.35B +$109M $76.25 85
2019 Q3 22.3M $1.13B +$1.13B $50.40 92